In the same context, recent evidence has revealed that mutation or lack of expression of FBXW7 contributes to BET inhibitors’ resistance, as in the case of T-cell leukemia cells by disruption of c-Myc degradation and its subsequent accumulation [46]. This evidence concerns the gene FBXW7 and T-cell leukemia.